Utah Medical Products, Inc.

Equities

UTMD

US9174881089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
65.92 ^USD	-0.56%		-3.88%	-21.73%

Apr. 25	Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q1 Revenue $11.3M	MT

Utah Medical Products, Inc. : Announces Quarterly Dividend

August 01, 2017 at 10:01 am EDT

SALT LAKE CITY, UT / ACCESSWIRE / August 1, 2017 / Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six and one-half cents ($.265) per share of common stock payable on October 3, 2017 to shareholders of record at the close of business on September 15, 2017. This is a 2% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc., with a particular interest in health care for women and their babies, develops, manufactures, and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.

Contact:

Paul Richins
(801) 566-1200

SOURCE: Utah Medical Products, Inc.

Latest news about Utah Medical Products, Inc.

Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Reports Q1 Revenue $11.3M	Apr. 25	MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q1 EPS $1.09	Apr. 25	MT
Utah Medical Products Keeps Quarterly Dividend at $0.30 Per Share, Payable on April 3 to Shareholders on March 15	Feb. 06	MT
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992.	Jan. 30	CI
Utah Medical Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 30	CI
Utah Medical Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 30	CI
North American Morning Briefing : Microsoft Kicks -2-	Jan. 30	DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992.	Nov. 13	CI
Utah Medical Products Lifts Quarterly Dividend by 1.7% to $0.30 a Share, Payable Jan. 3 to Shareholders of Record as of Dec. 15	23-10-31	MT
Utah Medical Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
North American Morning Briefing : Yields Fall -2-	23-10-24	DJ
Utah Medical Products Maintains Quarterly Dividend at $0.295/Share, Payable Oct. 3 to Shareholders of Record Sept. 15	23-08-01	MT
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023	23-08-01	CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 Revenue $12.9M	23-07-25	MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 EPS $1.15	23-07-25	MT
Utah Medical Products, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
North American Morning Briefing : Alphabet, -2-	23-07-25	DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992.	23-07-24	CI
Utah Medical Products Maintains Quarterly Dividend at $0.295 a Share, Payable July 6 to Shareholders of Record on June 16	23-05-09	MT
Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023	23-05-09	CI
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992.	23-04-25	CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q1 Revenue $12.5M	23-04-25	MT
Utah Medical Products, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023	23-02-07	CI

Chart Utah Medical Products, Inc.

Duration

Period

More charts

Company Profile

Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company's products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-29 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
UTAH MEDICAL PRODUCTS, INC.	-21.73%	238M
ABBOTT LABORATORIES	-2.31%	185B
MEDTRONIC PLC	-3.20%	105B
BECTON, DICKINSON AND COMPANY	-5.04%	66.59B
DEXCOM, INC.	+0.20%	54.66B
CENCORA, INC.	+17.29%	47.78B
HOYA CORPORATION	+4.06%	41.26B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.95B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.37B
TERUMO CORPORATION	+12.96%	24.8B

Other Medical Equipment, Supplies & Distribution